Tx response evaluation in RCC I.R.C.C.S. Policlinico San Matteo, Pavia

Slides:



Advertisements
Similar presentations
DIAGNOSTIC ROLE OF STATIC AND DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING IN THE EVALUATION OF SOFT TISSUE TUMOURS Abstract No. IRIA
Advertisements

Imaging modalities in prostate cancer
Adrenal Haemorrhage By Andrew McGovern Image: Underwood (2006) The use of different imaging methods in:
Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
Quantitative Biomarker Imaging for Early Therapy Response Assessment in Cancer James M. Mountz M.D., Ph.D., University of Pittsburgh Table 1: Clinical.
18F- FDG PET/CT in the Diagnosis of Tumor Thrombosis
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
The Dependence of the Apparent Diffusion Coefficient on Voxel Location and Calculation Method Lars Ewell 1, Naren Vijayakumar Meeting of the American.
Methods to Differentiate Radiation Induced Necrosis and Recurrent Disease in Gliomas Lars Ewell University of Arizona Medical Center Department of Radiation.
1 MRI Biomarkers for Cancer Assessment October 14, 2011 Jens Jensen Center for Biomedical Imaging and Department of Radiology.
JHSGR 16 th April 2011 Dr Lee Man Kit Derek.  The value of PET in staging adenocarcinoma (e.g. colorectal cancer) is well established Tomoharu T. et.
Role of MRI in Breast Cancer Angela Kong Princess Margaret Hospital.
Practice Guidelines and Consensus on Capsule Endoscopy
What can you see by MRI ? Stephen Paisey.
PET/CT & PET/MRI Radiopharmacy
ISSSMA June 3 rd Advanced quantification in oncology PET Irène Buvat IMNC – UMR 8165 CNRS – Paris 11 University Orsay, France
Management of DCIS Fei-Fei Liu Radiation Oncologist/Senior Scientist.
18 F-FET PET Compared with 18 F- FDG PET and CT in Patients with Head and Neck Cancer Present by Intern 羅穎駿 Journal of Nuclear Medicine Vol. 47 No
Tumor Measurement Criteria milestones & 2000
- Accurate Breast Cancer Detection Estimation - ABCDE - Costantino Giaconia, University of Palermo Mobile number:
Neo-adjuvant therapies for RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia.
Imaging Questions in Ovarian Cancer Susanna I. Lee, MD, PhD.
Imaging evaluation of clinical benefit in sarcomas: Dynamic MRI
Functional Imaging with PET for Sarcoma Rodney Hicks, MD, FRACP Director, Centre for Molecular Imaging Guy Toner, MD, FRACP Director, Medical Oncology.
Musculoskeletal Diagnostic Techniques ATHT 305 Chapter 5.
Sorveglianza attiva e trattamenti ablativi Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine.
Using Peak-Enhanced 2D-Capon Analysis with Single Voxel Magnetic Resonance Spectroscopy to Estimate T2* for Metabolites. Fred J. Frigo 1, James A. Heinen.
Correlation and fusion of perfusion and spectroscopic MR imaging for the characterisation of brain tumors A. Förschler 1), K. Vester 1), G. Peters 2),
“INTEGRAZIONE TRA TERAPIA CHIRURGICA E TERAPIA MEDICA” Camillo Porta, MD Medical Oncology I.R.C.C.S. San Matteo University Hospital Foundation, Pavia.
Early prediction of response Functional imaging Microarrays Proteomics.
Adjuvant therapies for RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia.
Response evaluation in RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia.
Laboratory for Product and Process Design Computer Assisted Design of Transport Processes in the Human Brain Laboratory for Product and Process Design,
University of Michigan Department of Radiology Role of MR Spectroscopy in Differentiating Radiation Necrosis from Tumor Recurrence. Effects of radiation.
Azienda Ospedaliero-Universitaria, Arcispedale S. Anna,
S. CONDETTE-AULIAC 1, A. BOULIN 1, O. COSKUN 1, L. BOZEC-LE MOAL 2, S. ALDEA 3, S.GUIEU 1, G. RODESCH 1. 1 Neuroradiology department, 2 Oncology department,
Figure 4 PET imaging in experimental pancreatic cancer
Sérgio Barroso Department of Oncology
Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer 
Don Nguyen1, Sean Li1, Jinxing Yu, MD1
Comparison of MR-permeability imaging from 11C-methionine PET in differentiating radiation necrosis from recurrent metastatic tumors of the brain after.
Klinikum rechts der Isar, Technische Universität München
CT Scan vs MRI.
Radiology 2005;236: Intern 陳君豪 2005/08/17
Non-Syndromic Optic Chiasm Mass in an Adult
Evidence-Base Medicine
MR Perfusion and Diffusion Values in Gliomas
COLORECTAL LIVER METASTASES:
Scheme: Optically-detected MRI
In vivo MR Spectroscopy
Figure 2 Response after initial increase in total tumour burden
Figure 3 Response after appearance of a new lesion
Medical Imaging Imagining Modalities.
Predict the splitting patterns of the protons in a given molecule.
Figure 2 Multiscale modelling in oncology
Figure 5 Schematic illustration of different clinical trial designs
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 5 Identification of mucinous carcinoma
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Volume 65, Issue 4, Pages (April 2014)
Avinash Kambadakone Ramesh1
Nat. Rev. Urol. doi: /nrurol
Baselga J et al. SABCS 2009;Abstract 45.
Nat. Rev. Clin. Oncol. doi: /nrclinonc
I.R.C.C.S. Policlinico San Matteo, Pavia
Example of pretreatment (A and B) and 8-week posttreatment (C and D) PET CT images. Example of pretreatment (A and B) and 8-week posttreatment (C and D)
Role of 3T multiparametric-MRI with BOLD hypoxia imaging for diagnosis and post therapy response evaluation of postoperative recurrent cervical cancers 
Frequency of lesions detected using CNS imaging (computed tomography [CT] and magnetic resonance imaging [MRI]) on patients with baylisascariasis (see.
INTRODUCTION TO RADIOLOGY IMAGING MODALITIES Asilah Al-Obeidani.
New directions for enhanced 13C imaging of brain cancer.
Presentation transcript:

Tx response evaluation in RCC I.R.C.C.S. Policlinico San Matteo, Pavia Issues relative to Tx response evaluation in RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia

take into account that … We should take into account that … RCC is an extremely peculiar cancer in terms of response evaluation ... ... mainly due to its unique molecular pathogenesis

From biology to the clinic

Peculiarities of targeted agents in terms of MOA ASL MRI H&E stain (2x); CD34 stain (20x) Rini B, Atkins M. Lancet Oncol 2009;10:992-1000

Peculiarities of targeted agents in terms of MOA 10 x 6 cm 11 x 7 cm Abou-Alfa GK, et al. J Clin Oncol 2006;24:4293–300

Peculiarities of targeted agents in terms of MOA Baseline Follow-up 1 Follow-up 2 Volume (cm3) 295 341 285 % necrosis 2.09 53.07 51.03 Abou-Alfa GK, et al. J Clin Oncol 2006;24:4293–300

Peculiarities of targeted agents in terms of MOA Baseline After 4 weeks of sorafenib therapy Gatzemeier U, et al. ASCO 2006, Atlanta, GA, USA

From biology to the clinic

18FDG PET and its limitations in RCC Rioja J, et al. BJU Int 2010;106:1578-93

Easy and cost-effective, but … Color-Doppler CEUS to predict PFS Baseline Week 6 Courtesy of Escudier B (ASCO 2005)

Girentuximab (anti-CAIX MoAb) Other tracers: Girentuximab (anti-CAIX MoAb) Stillebroer AB, et al. Eur Urol 2010;58:75-83 Stillebroer AB, et al. Cancer Imaging 2007;7:179-88

Girentuximab (anti-CAIX MoAb) Other tracers: Girentuximab (anti-CAIX MoAb)

Some lesions are neither measurable nor easily evaluable Therasse P, et al. J Natl Cancer Inst 2000;24:205–16

The future could be … Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) Potential: May be used to study microvascular density, vascular permeability, extravascular/extracellular space What we know: Successful therapies result in changes in DCE-MRI contrast-enhancement parameters which may prove to be accurate and early indicators of response One study demonstrated that DCE-MRI may act as a sensitive biomarker for response to the VEGFR inhibitor PTK787/ZK2225841 Pitfalls: High variability of the methods used for data acquisition and analysis lack of a general consensus on how best to acquire and/or analyse data Only consensus recommendations are, at present, available2 1Morgan B, et al. J Clin Oncol 2003;21:3955–64 2Evelhoc J, et al. NCI Cancer Imaging Program (http://imaging.cancer.gov)

The future could be … Magnetic Resonance Spectroscopy (MRS) What it is: An application of MRI that provides chemical information about specific tissue metabolites How it works: Conventional MRI detects the NMR spectra of water in tissues, while MRS detects the resonance spectra of chemical compounds other than water, allowing for a true depiction of in situ chemistry This is distinctive for many pathological conditions, including cancer, and for different metabolic states (eg, necrosis) Pitfalls: Expensive Validated only for brain tumours Lack of standardisation Increased level of choline and a decreased level of N-acetylaspartate, a pattern indicative of recurrent glioma and radiation necrosis

In conclusion … We badly need new response criteria for molecularly targeted agents Also in this field, enrollment of patients into specifically designed studies is crucial

Thank You for Your kind attention!!! c.porta@smatteo.pv.it